GPSM2 and hepatocellular carcinoma: Our current findings together with these reports suggest that CHEK1-hsa-mir-195-5p, CHEK1-hsa-mir-497-5p, and GPSM2-hsa-mir-122-5p may be key pathways in pathogenesis of hepatocellular carcinoma.